P128 - EVALUATING A PLANT-BASED ORAL NUTRITIONAL SUPPLEMENT USING FABA BEAN ISOLATE: A SUSTAINABLE AND ALLERGEN-FREE ALTERNATIVE FOR CLINICAL NUTRITION

Linked sessions

P128

EVALUATING A PLANT-BASED ORAL NUTRITIONAL SUPPLEMENT USING FABA BEAN ISOLATE: A SUSTAINABLE AND ALLERGEN-FREE ALTERNATIVE FOR CLINICAL NUTRITION

B. Green1, A. Johnson2, S. Medlin3, R. Conroy4, P. Harrison5, S. Burnett6, A. Harper7, K. Purchase1, C. Duncalf8,*

1AYMES, NA, 2The Hereford Dietitian, Hereford, 3City Dietitians, London, 4Independent Researcher, NA, 5Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, 6St Helens and Knowsley Teaching Hospitals NHS Trust, St Helens, 7Northamptonshire Healthcare NHS Foundation Trust, Northamptom, 8AYMES, Leek, United Kingdom

 

Rationale: Oral nutritional supplements (ONS) are essential in managing disease-related malnutrition (DRM), yet many formulations rely on dairy-based proteins. While there has been a recent surge in plant-based ONS innovation, the protein sources used (pea and soy) still pose allergen risks and environmental concerns. Faba bean presents an interesting and sustainable alternative plant-based protein source that has not yet been studied in a clinical nutrition setting for the dietary management of DRM.

Methods: n=15 adult patients with or at risk of DRM (mean age: 48 years; BMI: 19.3 kg/m2) received at least 200ml (range: 200-600ml) of a vegan suitable, faba bean-based, ready-to-drink, 1.5kcal/ml ONS (Actagain Plant-Powered, AYMES) for 7-days. Compliance, palatability, gastrointestinal (GI) tolerance and safety were assessed at baseline (day 0) and at the intervention endpoint (day 7).  

Results: Compliance to Actagain Plant-Powered was good versus dietetic prescription (66-90%), palatability was excellent and GI tolerance remained stable with no adverse or serious adverse events reported.

Conclusion: Actagain Plant-Powered, offers a nutritionally viable, palatable, well-tolerated alternative to dairy and other plant-based formulations. The sourcing and processing of faba beans offer a more sustainable alternative to dairy, pea, and soy, demonstrating greater efficiency in land and water use while producing lower greenhouse gas emissions. Actagain Plant-Powered is presented in Tetra Pak, using 63% plant-based renewable materials and 4 x less plastic compared to HDPE, further reducing carbon emissions by 11%. The absence of common allergens expands the applicability of Actagain Plant-Powered in clinical settings, addressing dietary restrictions and ethical consumer preferences.

Disclosure of Interest: None declared